Arterial and Venous Occlusive Disease of the Retina Dr.M NAQEEB Assistant professor Um Al-Qura university.

Slides:



Advertisements
Similar presentations
Evan (Jake) Waxman MD PhD
Advertisements

Debilitating Eye Diseases
DIABETIC RETINOPATHY Diabetic retinopathy is a frequent cause of blindness. The exact cause of diabetic microvascular disease is unknown.
Response to questions Laboratory tests Ophthalmic test Ophthalmic treatments Prognosis How to fallow up.
21/4/ Pegaptanib Sodium ( MACUGEN) for Macular Edema Secondary to Central Retinal Vein Occlusion Mahmood J Showail.
Canadian Diabetes Association Clinical Practice Guidelines Retinopathy Chapter 30 Shelley R. Boyd, Andrew Advani, Filiberto Altomare, Frank Stockl.
SHAWN RICHARDS, MD MOSES LAKE CLINIC MOSES LAKE, WA Common Retinal Diseases.
Risk Factors for RVO and CRVO
DIABETIC RETINOPATHY.
Fundoscopic Examination
GH.Naderian, M.D.. Supra choroidal hemorrhage Cystoid macular edema Retinal detachment.
M.R.AKHLAGHI MD  It is based on ophthalmoscopic signs.
VISUAL LOSS IN THE ELDERLY
Leo Semes, OD Professor, Optometry UAB, Birmingham, AL.
Ophthalmology for Finals
Ischemic Heart Disease Group of diseases Most common cause of death in developed countries Terminology: 1.Angina pectoris 2.Myocardial infarction 3.Sudden.
AMD & Treatment Options
Diabetic Retinopathy Steven Sanislo, M.D. Assistant Professor Stanford University Department of Ophthalmology.
Topic assignment : medical ophthalmology
 70yo woman presents with sudden onset loss of vision in her right eye half hour ago  No improvement since  No previous ophthalmic history  What are.
CASE V CENTRAL RETINAL VEIN OCCLUSION. Patient History; 52yo female Cc: Colorless, gray spot interfering with vision, OS. Began this morning, comes and.
Hemi Central Retinal Vein Occlusion
Occlusive vascular disorders of the retina Ayesha S abdullah
HYPERTENSIVE RETINOPATHY DR AJAY DUDANI DR YASHESH MANIAR.
Retinal vascular diseases 2
RETINAL VEIN OCCLUSION
Story of a 58 year old obese man’s retina Extra Case 5.
Mobility Program Information on eye diseases and disorders was obtained at the St. Lukes Eye Clinic Website
Diabetes and the Eyes Kenyon Anderson, O.D.. Blindness Risk Diabetic eye disease, caused by diabetes, is a leading cause of blindness and vision loss.
Ocular Ischaemic Syndrome Dr Gulrez Ansari Department of Ophthalmology Watford General Hospital 3 rd November 2004.
Diabetic Retinopathy.
Direct Ophthalmoscope
Acute and Chronic visual loss By Dr. ABDULMAJID ALSHEHAH Ophthalmology consultant Anterior Segment and Uveitis consultant.
Retinal Vein Occlusions
Visual Impairment. Factors Affecting Visual Function and Their Treatment Visual Acuity - ability to see "detail" –Measured using testing distance/letter.
OPHTHALMOLOGY DIABETES
Elsevier items and derived items © 2009 by Saunders, an imprint of Elsevier Inc. Coronary Artery Disease Coronary artery disease: A condition involving.
Stroke by: Katarina Batinjan Mentor: A. Ž mega č Horvat.
Anatomy. Examination method. Congenital & developmental anomalies. Retinal inflammation. Vascular disorder. Age-related macular degeneration. Retinal.
Chronic Visual Loss. CHRONIC VISUAL LOSS 1. Measure intraocular pressure with a tonometer 2. Evaluate the nerve head 3. Evaluate the clarity of the lens.
Amusing Slide 2013 WTD OPHTH ®.
Pathological changes of the fundus in general diseases .
RETINA Dr. G. Rajasekhar D.N.B, FRCS (Glasgow). RETINA  ARTERY OCCLUSIONS  VEIN OCCLUSIONS  DIABETIC RETINOPATHY  CENTRAL SEROUS RETINOPATHY  HYPERTENSIVE.
Dr. Ramezani Assistant Professor of Ophthalmology Kermanshah University of Medical Science.
Acute Painless Loss of Vision
Dr. Behboudi. Ophthalmologist vitreoretinal surgeon 2016.
BRVO. Present by Sattar Heidari MD General ophthalmologist.
Old Fibrotic Vascular tissue in End-Stage Proliferative Retinopathy
Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Inhibition of Neovascularization but Not Fibrosis.
Retina Imaging Conference Tala Kassm DO April 14, 2016 University of Louisville Department of Ophthalmology and Visual Sciences.
Acute Painless Loss of Vision
RETINAL VASCULAR DISEASES
HYPERTENSIVE RETINOPATHY
OVD of the retina CRAO Hypertensive retinopathy Ayesha S abdullah
Review Coats’ disease AP.박영훈 / Ap.김규섭/ R2 유애리.
Dr.Ravi kant Associate Professor Medicine ,AIIMS Rishikesh
Ultra Wide-Field Angiographic Characteristics of Branch Retinal and Hemicentral Retinal Vein Occlusion Ophthalmology 2010;117 Ap. 양지욱/R4 김성일.
Systemic Diseases.
Acute Visual Loss Saeed Alwadani, MD Assistant Professor
DIABETIC RETINOPATHY Süleyman ÖZEN.
Branch retinal artery occlusion (brao )
In the name of GOD.
In the name of god Pathophysiology of retinal vein occlusion Hamid Fesharaki MD Eye department Isfahan University of medical sciences.
Central Retinal Artery Occlusion
January 16, 2019.
“Young Female with Painless Blurry Vision”
Retinal vascular disease
Presentation transcript:

Arterial and Venous Occlusive Disease of the Retina Dr.M NAQEEB Assistant professor Um Al-Qura university

Objective 1. Central retinal artery occlusion 2. Branch retinal artery occlusion 3. Branch retinal vein occlusion 4. Central retinal vein occlusion

retinal artery obstructions u 57% of obstructions involved the central retinal artery u 38% involved one of the branch retinal arteries u 5% involved the cilioretinal artery

Central Artery Obstruction u Characteristics v Sudden severe visual loss v Painless v Retinal appearance »Opaque and edematous u Most prominent in posterior pole –Thickest ganglion cell layer »Cherry-red spot u Visible intact choroidal vasculature beneath the foveola

Central Artery Obstruction u Characteristics v With time »Artery re-canalizes »Edema clears »Visual loss is devastating and permanent u Irreversible damage to neural tissue after 90 minutes

Intravenous fluorescein angiography

Central Artery Obstruction u Prognosis v 20/400 or worse: 2/3 of eyes v 20/40 or better: 1/6 eyes »Intact cilioretinal artery v Vision of NLP »Implies ophthalmic artery occlusion u Choroidal ischemia as well

Central Artery Obstruction u Pathogenesis v Majority »atherosclerosis-related thrombosis u At the level of the lamina cribrosa v Other causes »Arterial spasm »Dissecting aneurysm »GIANT CELL ARTERITIS u 1% of cases –Check ESR in elderly patients! –Start high does steroids if suspicious

Central Artery Obstruction u Management v No good therapy exists, all treatments questionable »Ocular message »Anterior chamber paracentesis u Attempt to acutely reduce IOP u Dislodge thrombosis »Inhalation therapy u 95%O 2, 5%CO 2 –Stimulate vasodilatation v Iris neovascularization »Occurs in 18% of eyes u 1-12 weeks later (usually 3-4 weeks later) »Full PRP treatment required

Branch Retinal Artery Obstruction u Characteristics v Vision loss v Visual filed defect v Within hours/days »Edematous opacification of the retina u In the distribution of the affected vessel

Branch Retinal Artery Obstruction u Pathogenesis v Embolization or thrombosis of vessel v Three types of emboli »Cholesterol u Hollenhorst plaques u Arise from carotid »Platelet-fibrin u Associated with arteriosclerosis »Calcific u Diseased cardiac valves

Retinal Embolization u Hollenhorst plaque v Glistening cholesterol emboli v Found within retinal arteriole »Typically lodge at bifurcations v Arise in carotid arteries

Retinal Embolization u Hollenhorst plaque v Glistening cholesterol emboli v Found within retinal arteriole »Typically lodge at bifurcations v Arise in carotid arteries

Branch Retinal Artery Obstruction u Other causes of BRVO v Migraine »Particularly in smokers v Trauma v Coagulation disorders v Sickle cell disease v Oral contraceptive use »Smoking, older women v Mitral valve prolapse v Infections »Toxoplasmosis, syphilis v Giant cell arteritis »Check ESR in elderly patients u Good prognosis

Workup u ESR,CBC and C-reactive protein u Fasting blood sugar u Glycosylated hemoglobin u Doppler US for carotid artery u ECG, echocardiogram u Refer for haematology

Mortality/Morbidity u Further emboli to the brain resulting in CVA v 55% death over 10 years v 27% age matched population u Further emboli to same or contralateral eye resulting in further visual loss u Progression of temporal arteritis

Venous Occlusive Disease

Central Retinal Vein Occlusion u Findings v Dilated and tortuous retinal veins v Swollen optic disc v Intra-retinal hemorrhages v Retinal edema All four quadrants

Central Retinal Vein Occlusion u Classification v Based on amount of non-profusion on fluorescein angiography »Ischemic u ≥10 disk areas »Non-ischemic u < 10 disk areas »Indeterminate u Too much hemorrhage to tell u 80% progress to ischemic

Central Retinal Vein Occlusion u Pathogenesis v Thrombosis of the central retinal vein »At or posterior to the lamina cribrosa v Atherosclerotic central retinal artery »Impinges on central retinal vein u Turbulent flow → thrombus

Central Retinal Vein Occlusion u Non-ischemic CRVO v Less dilation and vascular tortuosity v Dot and flame hemorrhages in all quadrants v Less or no disk swelling v Angiogram shows »Delayed A-V transit time »Leakage »Minimal capillary dropout v Neovascularization is rare

Central Retinal Vein Occlusion u Ischemic CRVO v Extensive hemorrhage v Retinal edema v Marked venous dilation v Cotton-wool spots v Angiogram show »Widespread capillary nonprofusion v Visual prognosis poor »Only 10% have >20/400 vision v NVI »As high as 60% of eyes »Occurs 3-5 months post occlusion u “the three month glaucoma”

Central Retinal Vein Occlusion u Risk Factors v Eye Disease Case-Control Study »Hypertension »Diabetes u Unlike BRVO »Glaucoma u Check and treat IOP! v CRVO in young patients requires more extensive workup for cause

CRVO In Young Patients – Causes u Systemic vascular disease v Hypertension v Diabetes mellitus v Cardiovascular disease u Blood dyscrasias v Polycythemia vera v Lymphoma v Leukemia u Clotting disorders v Activated protein C resistance v Lupus anticoagulant v Anticardiolipin antibodies v Protein C v Protein S v Antithrombin III u Paraproteinemia and dysproteinemias v Multiple myeloma v Cryoglobulinemia u Vasculitis v Syphilis v Sarcoidosis u Autoimmune disease v Systemic lupus erythematosus u Oral contraceptive use in women u Other rare associations v Closed-head trauma v Optic disc drusen v Arteriovenous malformations of retina

Central Retinal Vein Occlusion u Management v Family medical doctor to manage »Hypertension »Diabetes »Elevated cholesterol

Central Retinal Vein Occlusion u Management v Macular edema »Central Vein Occlusion Study Group u Grid laser treatment in the macula –DOES reduce angiographic evidence of edema –DOES NOT improve vision

Central Retinal Vein Occlusion u Management v Macular edema »Intravitreal trimcinolone/Avastin »Capable of transiently improving vision u Risks –Glaucoma –RD –Cataract –Endopthalmitis

Central Retinal Vein Occlusion u Management v Iris neovascularization v PRP to eyes prior to NVI »NO benefit u Even if very ischemic v Once neovascularization detected »Prompt PRP

Central Retinal Vein Occlusion u Outcome v Most important predictor is initial visual acuity: »20/40 or better u Likely to remain unchanged »20/400 or less u Likely to remain worse than 20/400 »20/50-20/200 u 1/3 unchanged u 1/3 improve u 1/3 worse

Branch Retinal Vein Occlusion u Findings v Within one sector of the retina »Superficial hemorrhages »Retinal edema »Cotton-wool spots »Dilated and tortuous vein »Corresponding artery narrowed and sheathed

Branch Retinal Vein Occlusion u Findings v Superotemporal quadrant most common »63% v Occurs at arteriovenous crossing »Artery and vein bound together in a common sheath »Arterial thickening compresses vein u Turbulent flow → thrombus formation

Branch Retinal Vein Occlusion u Risk factors v Identified by the Eye Disease Case-Control Study »Hypertension »Cardiovascular disease »Increased BMI at age 20 »Glaucoma v Note : Diabetes not an independent risk factor

Branch Retinal Vein Occlusion u Visual Loss v Acute »Macular hemorrhage »Macular edema »Capillary occlusion v Chronic »Macular ischemia »CME »Macular pigmentary changes »Epiretinal membrane formation »Subretinal fibrosis

Branch Retinal Vein Occlusion u Photocoagulation v Used to treat: »Macular edema u Requires intact foveal perfusion »Neovascularization v Macular edema »Allow three months for improvement »Vision 20/40 or worse »Light grid pattern of laser spots to involved sector of retina »Branch vein occlusion study u Treated eyes more likely to gain 2 lines of vision –Treated 65%, untreated 37%

Branch Retinal Vein Occlusion u Photocoagulation v Neovascularization »BVOS defined ischemic BRVO u Area of non-profusion > 5 disk diameters »Large areas of non-profusion increase risk of neovascularization v Apply scatter PRP to areas of retinal ischemia »Only when neovascular complications develop u NVI, NVE, NVD

Branch Retinal Vein Occlusion Vascular Remodeling u Photocoagulation »Must differentiate u Neovascular tissue –Leaks on fluorscein angiogram u Collateral vessels –Help to reduce vascular tissue –Do not treat

Thank you xoxo